Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study

NCT03929913 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT03929913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03929913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Not applicable
Overall status
Completed
Start date
May 7, 2019
Completion date
February 27, 2026
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation